Medicare AdvantageCoverageMedium impact
MA11.022a, Cryosurgical Ablation of the Prostate Gland
Independence Blue Cross·Urology·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.022a regarding cryosurgical ablation of the prostate gland has been reissued and will take effect April 2, 2025. This is a policy update that may affect coverage, billing, or documentation requirements for prostate cryosurgery procedures.
Action Required
By April 2, 2025: Billing team must review the complete MA11.022a policy for cryosurgical ablation of the prostate gland to identify any changes in coverage criteria, prior authorization requirements, or documentation standards. Update billing workflows and encounter forms as needed for Medicare Advantage plans.